Acetazolamide Completed Phase 2 Trials for Pulmonary Hypertension (PH) / Breathing-Related Sleep Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01427192Treatment of Sleep Related Breathing Disorders in Patients With Pulmonary Hypertension